Showing results (401-410 of 459) with videos related to
Sort By:
Pageof 46
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 24, 2004
A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorderH Ewald, F P Wikman, B M Teruel, et al.Antiviral Therapy|June 26, 2014
Impact of prior virological failure and nucleos(t)ide genotypic resistance mutations on the efficacy of switching from ritonavir-boosted protease inhibitors to raltegravirJosé L Blanco, Ana Gonzalez-Cordón, Josep M Llibre, et al.Annals of Botany|May 5, 2021
Inter-annual and spatial climatic variability have led to a balance between local fluctuating selection and wide-range directional selection in a perennial grass speciesT Keep, S Rouet, J L Blanco-Pastor, et al.Revista De Neurologia|January 31, 2004
[Lesions in the pars compacta substantiae nigra and the subthalamic nucleus modify the density of muscarinic receptors in different nuclei of the basal ganglia]L Blanco-Lezcano, L L Rocha-Arrieta, L Martínez-Martí, et al.Ecology and Evolution|May 9, 2025
Environmental Data Do Not Correlate With Plant Genetic Diversity in Alpine EcosystemsJ L Blanco-Pastor, J Fajardo, A G Fernández de Castro, et al.The Journal of Antimicrobial Chemotherapy|March 28, 2024
Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudineElisa de Lazzari, Eugenia B Negredo, Pere Domingo, et al.AIDS (London, England)|May 11, 2018
A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicityJhon Rojas, Jose L Blanco, Sonsoles Sanchez-Palomino, et al.Enfermedades Infecciosas Y Microbiologia Clinica|June 23, 2005
[Renal transplantation in patients with HIV infection]Joan-Carles Trullás, José M Miró, Guillermina Barril, et al.The Journal of Antimicrobial Chemotherapy|May 1, 2013
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypesLourdes Anta, José L Blanco, Josep M Llibre, et al.The Lancet. HIV|August 6, 2021
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trialJhon Rojas, Elisa de Lazzari, Eugenia Negredo, et al.Pageof 46